Jamie Waselenko is an Oncology physician affiliated with Oncology Hematology Care. OpenAlex indexes 24 publications with 2,655 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4460 Red Bank Rd
Suite 200
Cincinnati, OH 452272172
Telephone
513-321-4333Provider last certified this registry record 2 Oct 2024.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pharmacosmos Therapeutics Inc.Program year20252 payments
- PFIZER INC.Program year20252 payments
- Stemline Therapeutics Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
61.7%Aromatase Inhibitor21.2%Anastrozole61%Letrozole39%Part D<11 patientsKinase inhibitor19.7%Imatinib Mesylate55%Brukinsa45%Part D<11 patients+ 2 more classes in this area
Dermatology
8.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor8.3%Acyclovir100%Part D<11 patientsMusculoskeletal
7.8%Xanthine oxidase inhibitor7.8%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dependence on Functional p53 Activation of Caspase-3 Without Evidence of bcl-2 Modulation or Flavopiridol Induces Apoptosis in Chronic Lymphocytic Leukemia Cells Via2011
- Acute Radiation Injury: Contingency Planning for Triage, Supportive Care, and Transplantation
Biology of Blood and Marrow Transplantation
2006
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Faber, DO, MS
Oncology Hematology Care
Bernard Hertzman, MD
Oncology Hematology Care
Akash Mukherjee, MD
Oncology Hematology Care
David Drosick, MD
Oncology Hematology Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”